Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a
Clinical trial NCT04773665 · COMPLETED
Trial details
- NCT number
- NCT04773665
- Sponsor
- VBI Vaccines Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-15
- Primary completion
- 2022-11-14
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.